Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 199

    1.

    The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

    Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J.

    Diabetes Care. 2004 Nov;27(11):2767. No abstract available. PMID: 15505023 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.

    Levy AP.

    Isr Med Assoc J. 2004 May;6(5):308-10. Review. No abstract available. PMID: 15151377 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.

    Levy AP, Blum S.

    Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1105-11. Review.PMID: 18035926 [PubMed - indexed for MEDLINE]Related articles

    4.

    Haptoglobin phenotypes in diabetes mellitus and diabetic retinopathy.

    Chandra T, Lakshmi CN, Padma T, Vidyavathi M, Satapathy M.

    Hum Hered. 1991;41(5):347-50.PMID: 1778611 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.

    Blum S, Milman U, Shapira C, Levy AP.

    Pharmacogenomics. 2008 Aug;9(8):989-91. No abstract available. PMID: 18681772 [PubMed - indexed for MEDLINE]Related articles

    6.

    Haptoglobin phenotype and coronary artery collaterals in diabetic patients.

    Hochberg I, Roguin A, Nikolsky E, Chanderashekhar PV, Cohen S, Levy AP.

    Atherosclerosis. 2002 Apr;161(2):441-6.PMID: 11888529 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.

    Blum S, Milman U, Shapira C, Miller-Lotan R, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP.

    Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):e18-20. No abstract available. PMID: 18296583 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [The distribution of haptoglobin-phenotypes and haptoglobin-alleles in some diseases (Diabetes mellitus, liver parenchyma damage, psoriasis vulgaris)]

    Jörgensen G, Hopfer A.

    Humangenetik. 1967;3(4):277-81. German. No abstract available. PMID: 6081910 [PubMed - indexed for MEDLINE]Related articles

    9.

    Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

    Asleh R, Blum S, Kalet-Litman S, Alshiek J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, Levy AP.

    Diabetes. 2008 Oct;57(10):2794-800. Epub 2008 Jul 3.PMID: 18599520 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.

    Asleh R, Levy AP.

    Vasc Health Risk Manag. 2005;1(1):19-28. Review.PMID: 17319095 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene.

    Levy AP.

    Acta Diabetol. 2003 Dec;40 Suppl 2:S330-3. Review.PMID: 14704863 [PubMed - indexed for MEDLINE]Related articles

    12.

    Genetic polymorphisms as determinants for disease-preventive effects of vitamin E.

    Zingg JM, Azzi A, Meydani M.

    Nutr Rev. 2008 Jul;66(7):406-14. Review.PMID: 18667016 [PubMed - indexed for MEDLINE]Related articles

    13.

    Vitamin E in diabetes. Increased oxidative stress and its prevention as a strategy to prevent vascular complications?

    Rösen P, Toeller M.

    Int J Vitam Nutr Res. 1999 May;69(3):206-12. Review. No abstract available. PMID: 10389029 [PubMed - indexed for MEDLINE]Related articles

    14.

    Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

    Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP.

    Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7. Epub 2007 Nov 21.PMID: 18032779 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.

    Costacou T, Ferrell RE, Orchard TJ.

    Diabetes. 2008 Jun;57(6):1702-6. Epub 2008 Mar 10.PMID: 18332093 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The impact of nuts on diabetes and diabetes risk.

    Lovejoy JC.

    Curr Diab Rep. 2005 Oct;5(5):379-84. Review.PMID: 16188174 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of the RAS and prevention of diabetes and CVD: mechanistic insights and lessons learned from clinical trials.

    McFarlane SI, Borer JS.

    Curr Diab Rep. 2009 Feb;9(1):1-3. No abstract available. PMID: 19192416 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.

    Miller-Lotan R, Herskowitz Y, Kalet-Litman S, Nakhoul F, Aronson D, Zoabi R, Asaf R, Ben-Izhak O, Sabo E, Lim SK, Baumann H, Berger FG, Levy AP.

    Diabetes Metab Res Rev. 2005 Jul-Aug;21(4):332-7.PMID: 15852445 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association of haptoglobin genotype in adolescents with type 1 diabetes mellitus and endothelial function: an unresolved issue.

    Shechter M.

    Isr Med Assoc J. 2007 Sep;9(9):671-3. No abstract available. PMID: 17939631 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data